nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—PTGS1—kidney cancer	0.109	0.336	CbGaD
Diclofenac—CYP1A1—kidney cancer	0.1	0.308	CbGaD
Diclofenac—PTGS2—kidney cancer	0.0626	0.192	CbGaD
Diclofenac—ABCB1—kidney cancer	0.0532	0.164	CbGaD
Diclofenac—UGT1A1—Pazopanib—kidney cancer	0.0328	0.0856	CbGbCtD
Diclofenac—ABCC1—Dactinomycin—kidney cancer	0.0246	0.0644	CbGbCtD
Diclofenac—UGT1A1—Erlotinib—kidney cancer	0.0234	0.0611	CbGbCtD
Diclofenac—ABCC4—Sorafenib—kidney cancer	0.0194	0.0508	CbGbCtD
Diclofenac—UGT1A1—Sorafenib—kidney cancer	0.019	0.0497	CbGbCtD
Diclofenac—ABCC1—Paclitaxel—kidney cancer	0.0176	0.046	CbGbCtD
Diclofenac—ABCC4—Sunitinib—kidney cancer	0.0158	0.0412	CbGbCtD
Diclofenac—ABCC1—Vinblastine—kidney cancer	0.0154	0.0403	CbGbCtD
Diclofenac—ABCC1—Vincristine—kidney cancer	0.0152	0.0396	CbGbCtD
Diclofenac—ABCB1—Temsirolimus—kidney cancer	0.0124	0.0323	CbGbCtD
Diclofenac—CYP1A1—Erlotinib—kidney cancer	0.0119	0.031	CbGbCtD
Diclofenac—CYP3A4—Everolimus—kidney cancer	0.011	0.0287	CbGbCtD
Diclofenac—CYP2C8—Pazopanib—kidney cancer	0.0096	0.0251	CbGbCtD
Diclofenac—ABCC1—Doxorubicin—kidney cancer	0.00948	0.0248	CbGbCtD
Diclofenac—ALB—Erlotinib—kidney cancer	0.00887	0.0232	CbGbCtD
Diclofenac—CYP1A2—Pazopanib—kidney cancer	0.00743	0.0194	CbGbCtD
Diclofenac—CYP3A4—Temsirolimus—kidney cancer	0.00741	0.0194	CbGbCtD
Diclofenac—CYP2B6—Sorafenib—kidney cancer	0.00736	0.0192	CbGbCtD
Diclofenac—CYP2C9—Capecitabine—kidney cancer	0.00699	0.0182	CbGbCtD
Diclofenac—CYP2C8—Erlotinib—kidney cancer	0.00685	0.0179	CbGbCtD
Diclofenac—ABCB1—Pazopanib—kidney cancer	0.0065	0.017	CbGbCtD
Diclofenac—CYP2C8—Paclitaxel—kidney cancer	0.00627	0.0164	CbGbCtD
Diclofenac—ABCB1—Dactinomycin—kidney cancer	0.00594	0.0155	CbGbCtD
Diclofenac—CYP2C8—Sorafenib—kidney cancer	0.00557	0.0146	CbGbCtD
Diclofenac—CYP1A2—Erlotinib—kidney cancer	0.0053	0.0139	CbGbCtD
Diclofenac—ABCB1—Gemcitabine—kidney cancer	0.0047	0.0123	CbGbCtD
Diclofenac—CYP2C19—Sorafenib—kidney cancer	0.00467	0.0122	CbGbCtD
Diclofenac—ABCB1—Erlotinib—kidney cancer	0.00464	0.0121	CbGbCtD
Diclofenac—CYP2B6—Doxorubicin—kidney cancer	0.00446	0.0117	CbGbCtD
Diclofenac—CYP2C9—Paclitaxel—kidney cancer	0.00437	0.0114	CbGbCtD
Diclofenac—CYP1A2—Sorafenib—kidney cancer	0.00431	0.0113	CbGbCtD
Diclofenac—ABCB1—Paclitaxel—kidney cancer	0.00425	0.0111	CbGbCtD
Diclofenac—CYP3A4—Pazopanib—kidney cancer	0.00389	0.0102	CbGbCtD
Diclofenac—CYP2C9—Sorafenib—kidney cancer	0.00389	0.0102	CbGbCtD
Diclofenac—ABCB1—Sorafenib—kidney cancer	0.00377	0.00985	CbGbCtD
Diclofenac—ABCB1—Vinblastine—kidney cancer	0.00372	0.00973	CbGbCtD
Diclofenac—ABCB1—Vincristine—kidney cancer	0.00366	0.00956	CbGbCtD
Diclofenac—ABCB1—Sunitinib—kidney cancer	0.00306	0.00798	CbGbCtD
Diclofenac—TTR—urine—kidney cancer	0.0029	0.0661	CbGeAlD
Diclofenac—CYP3A4—Erlotinib—kidney cancer	0.00278	0.00726	CbGbCtD
Diclofenac—UGT1A1—urine—kidney cancer	0.00275	0.0627	CbGeAlD
Diclofenac—CYP3A4—Paclitaxel—kidney cancer	0.00254	0.00664	CbGbCtD
Diclofenac—ABCB1—Doxorubicin—kidney cancer	0.00229	0.00598	CbGbCtD
Diclofenac—CYP3A4—Sorafenib—kidney cancer	0.00226	0.0059	CbGbCtD
Diclofenac—CYP3A4—Vinblastine—kidney cancer	0.00223	0.00583	CbGbCtD
Diclofenac—SLC22A8—nephron—kidney cancer	0.00222	0.0505	CbGeAlD
Diclofenac—CYP3A4—Vincristine—kidney cancer	0.00219	0.00573	CbGbCtD
Diclofenac—CYP3A4—Sunitinib—kidney cancer	0.00183	0.00478	CbGbCtD
Diclofenac—SLC22A8—urine—kidney cancer	0.00178	0.0405	CbGeAlD
Diclofenac—CYP2C19—urine—kidney cancer	0.00149	0.034	CbGeAlD
Diclofenac—CYP3A4—Doxorubicin—kidney cancer	0.00137	0.00358	CbGbCtD
Diclofenac—PTGS2—nephron—kidney cancer	0.00126	0.0287	CbGeAlD
Diclofenac—CYP1A2—urine—kidney cancer	0.00122	0.0277	CbGeAlD
Diclofenac—CYP2C9—urine—kidney cancer	0.00116	0.0263	CbGeAlD
Diclofenac—CYP2E1—urine—kidney cancer	0.00109	0.025	CbGeAlD
Diclofenac—CXCL8—nephron tubule—kidney cancer	0.00102	0.0233	CbGeAlD
Diclofenac—KCNQ2—gonad—kidney cancer	0.00102	0.0233	CbGeAlD
Diclofenac—PLA2G2A—renal system—kidney cancer	0.00094	0.0214	CbGeAlD
Diclofenac—PLA2G2A—kidney—kidney cancer	0.000908	0.0207	CbGeAlD
Diclofenac—CYP3A4—urine—kidney cancer	0.000881	0.0201	CbGeAlD
Diclofenac—SLC22A11—nephron tubule—kidney cancer	0.000848	0.0193	CbGeAlD
Diclofenac—PLA2G2A—cardiac atrium—kidney cancer	0.000842	0.0192	CbGeAlD
Diclofenac—SLC22A6—nephron tubule—kidney cancer	0.000799	0.0182	CbGeAlD
Diclofenac—SLCO1C1—renal system—kidney cancer	0.000794	0.0181	CbGeAlD
Diclofenac—UGT2B7—renal system—kidney cancer	0.000791	0.018	CbGeAlD
Diclofenac—SLC22A11—renal system—kidney cancer	0.000771	0.0176	CbGeAlD
Diclofenac—SLCO1C1—kidney—kidney cancer	0.000767	0.0175	CbGeAlD
Diclofenac—UGT2B7—kidney—kidney cancer	0.000765	0.0174	CbGeAlD
Diclofenac—SLC22A11—kidney—kidney cancer	0.000745	0.017	CbGeAlD
Diclofenac—SCN4A—renal system—kidney cancer	0.000729	0.0166	CbGeAlD
Diclofenac—SLC22A11—cortex of kidney—kidney cancer	0.000726	0.0165	CbGeAlD
Diclofenac—TTR—renal system—kidney cancer	0.000709	0.0162	CbGeAlD
Diclofenac—SCN4A—kidney—kidney cancer	0.000705	0.0161	CbGeAlD
Diclofenac—TTR—kidney—kidney cancer	0.000686	0.0156	CbGeAlD
Diclofenac—SLC22A6—cortex of kidney—kidney cancer	0.000684	0.0156	CbGeAlD
Diclofenac—UGT1A1—renal system—kidney cancer	0.000673	0.0153	CbGeAlD
Diclofenac—UGT1A1—kidney—kidney cancer	0.00065	0.0148	CbGeAlD
Diclofenac—ABCC4—nephron tubule—kidney cancer	0.000482	0.011	CbGeAlD
Diclofenac—SLC22A8—nephron tubule—kidney cancer	0.000478	0.0109	CbGeAlD
Diclofenac—Bromfenac—PTGS1—kidney cancer	0.000454	0.147	CrCbGaD
Diclofenac—ABCC4—renal system—kidney cancer	0.000438	0.00999	CbGeAlD
Diclofenac—SLC22A8—renal system—kidney cancer	0.000435	0.00991	CbGeAlD
Diclofenac—ABCC4—kidney—kidney cancer	0.000424	0.00966	CbGeAlD
Diclofenac—SLC22A8—kidney—kidney cancer	0.00042	0.00958	CbGeAlD
Diclofenac—ABCC4—cortex of kidney—kidney cancer	0.000413	0.00941	CbGeAlD
Diclofenac—SLC22A8—cortex of kidney—kidney cancer	0.000409	0.00933	CbGeAlD
Diclofenac—Lumiracoxib—PTGS1—kidney cancer	0.000386	0.125	CrCbGaD
Diclofenac—Nepafenac—PTGS1—kidney cancer	0.000367	0.119	CrCbGaD
Diclofenac—ABCC1—cortex of kidney—kidney cancer	0.000352	0.00802	CbGeAlD
Diclofenac—ABCC1—cardiac atrium—kidney cancer	0.000335	0.00763	CbGeAlD
Diclofenac—CYP2C8—renal system—kidney cancer	0.000318	0.00725	CbGeAlD
Diclofenac—CYP2B6—nephron tubule—kidney cancer	0.000314	0.00716	CbGeAlD
Diclofenac—CYP2C8—kidney—kidney cancer	0.000308	0.00701	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS1—kidney cancer	0.000301	0.0975	CrCbGaD
Diclofenac—CYP1A2—renal system—kidney cancer	0.000298	0.00679	CbGeAlD
Diclofenac—CYP2E1—nephron tubule—kidney cancer	0.000295	0.00672	CbGeAlD
Diclofenac—CYP1A1—renal system—kidney cancer	0.000294	0.0067	CbGeAlD
Diclofenac—CYP2B6—renal system—kidney cancer	0.000285	0.00651	CbGeAlD
Diclofenac—CYP1A1—kidney—kidney cancer	0.000284	0.00647	CbGeAlD
Diclofenac—CYP2B6—kidney—kidney cancer	0.000276	0.00629	CbGeAlD
Diclofenac—CYP2E1—renal system—kidney cancer	0.000268	0.00611	CbGeAlD
Diclofenac—CYP1A1—cardiac atrium—kidney cancer	0.000263	0.006	CbGeAlD
Diclofenac—Bromfenac—PTGS2—kidney cancer	0.00026	0.0841	CrCbGaD
Diclofenac—CYP2E1—kidney—kidney cancer	0.000259	0.0059	CbGeAlD
Diclofenac—PTGS1—renal system—kidney cancer	0.000258	0.00588	CbGeAlD
Diclofenac—CYP2B6—gonad—kidney cancer	0.000256	0.00584	CbGeAlD
Diclofenac—CYP2E1—cortex of kidney—kidney cancer	0.000252	0.00575	CbGeAlD
Diclofenac—PTGS1—kidney—kidney cancer	0.000249	0.00569	CbGeAlD
Diclofenac—PTGS2—renal system—kidney cancer	0.000247	0.00562	CbGeAlD
Diclofenac—PTGS2—kidney—kidney cancer	0.000238	0.00544	CbGeAlD
Diclofenac—Mefenamic acid—PTGS1—kidney cancer	0.000234	0.0758	CrCbGaD
Diclofenac—PTGS1—cardiac atrium—kidney cancer	0.000231	0.00527	CbGeAlD
Diclofenac—Clonidine—CYP1A1—kidney cancer	0.000228	0.0737	CrCbGaD
Diclofenac—Lumiracoxib—PTGS2—kidney cancer	0.000221	0.0715	CrCbGaD
Diclofenac—CYP3A4—renal system—kidney cancer	0.000216	0.00491	CbGeAlD
Diclofenac—Nepafenac—PTGS2—kidney cancer	0.00021	0.068	CrCbGaD
Diclofenac—CYP3A4—kidney—kidney cancer	0.000208	0.00475	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS2—kidney cancer	0.000172	0.0557	CrCbGaD
Diclofenac—ABCB1—nephron tubule—kidney cancer	0.000168	0.00383	CbGeAlD
Diclofenac—ABCB1—renal system—kidney cancer	0.000153	0.00348	CbGeAlD
Diclofenac—ABCB1—kidney—kidney cancer	0.000147	0.00336	CbGeAlD
Diclofenac—ABCB1—cortex of kidney—kidney cancer	0.000144	0.00327	CbGeAlD
Diclofenac—ABCB1—gonad—kidney cancer	0.000137	0.00312	CbGeAlD
Diclofenac—Mefenamic acid—PTGS2—kidney cancer	0.000134	0.0433	CrCbGaD
Diclofenac—Clonidine—ABCB1—kidney cancer	0.000121	0.0392	CrCbGaD
Diclofenac—Vomiting—Sorafenib—kidney cancer	3.7e-05	0.00023	CcSEcCtD
Diclofenac—Abdominal pain upper—Doxorubicin—kidney cancer	3.7e-05	0.00023	CcSEcCtD
Diclofenac—Nervous system disorder—Paclitaxel—kidney cancer	3.69e-05	0.00023	CcSEcCtD
Diclofenac—Thrombocytopenia—Paclitaxel—kidney cancer	3.69e-05	0.000229	CcSEcCtD
Diclofenac—Tachycardia—Paclitaxel—kidney cancer	3.67e-05	0.000229	CcSEcCtD
Diclofenac—Rash—Sorafenib—kidney cancer	3.67e-05	0.000229	CcSEcCtD
Diclofenac—Dermatitis—Sorafenib—kidney cancer	3.67e-05	0.000228	CcSEcCtD
Diclofenac—Back pain—Capecitabine—kidney cancer	3.66e-05	0.000228	CcSEcCtD
Diclofenac—Skin disorder—Paclitaxel—kidney cancer	3.66e-05	0.000228	CcSEcCtD
Diclofenac—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	3.65e-05	0.000227	CcSEcCtD
Diclofenac—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	3.65e-05	0.000227	CcSEcCtD
Diclofenac—Headache—Sorafenib—kidney cancer	3.65e-05	0.000227	CcSEcCtD
Diclofenac—Muscle spasms—Capecitabine—kidney cancer	3.64e-05	0.000226	CcSEcCtD
Diclofenac—Hyperhidrosis—Paclitaxel—kidney cancer	3.64e-05	0.000226	CcSEcCtD
Diclofenac—Diarrhoea—Dactinomycin—kidney cancer	3.63e-05	0.000226	CcSEcCtD
Diclofenac—Nasopharyngitis—Doxorubicin—kidney cancer	3.62e-05	0.000225	CcSEcCtD
Diclofenac—Anorexia—Paclitaxel—kidney cancer	3.59e-05	0.000223	CcSEcCtD
Diclofenac—Gastritis—Doxorubicin—kidney cancer	3.59e-05	0.000223	CcSEcCtD
Diclofenac—Muscular weakness—Doxorubicin—kidney cancer	3.57e-05	0.000222	CcSEcCtD
Diclofenac—Alanine aminotransferase increased—Doxorubicin—kidney cancer	3.57e-05	0.000222	CcSEcCtD
Diclofenac—Vision blurred—Capecitabine—kidney cancer	3.57e-05	0.000222	CcSEcCtD
Diclofenac—Vomiting—Sunitinib—kidney cancer	3.56e-05	0.000222	CcSEcCtD
Diclofenac—Body temperature increased—Gemcitabine—kidney cancer	3.55e-05	0.000221	CcSEcCtD
Diclofenac—Tremor—Capecitabine—kidney cancer	3.55e-05	0.000221	CcSEcCtD
Diclofenac—Rash—Sunitinib—kidney cancer	3.53e-05	0.00022	CcSEcCtD
Diclofenac—Dermatitis—Sunitinib—kidney cancer	3.53e-05	0.00022	CcSEcCtD
Diclofenac—Abdominal distension—Doxorubicin—kidney cancer	3.53e-05	0.000219	CcSEcCtD
Diclofenac—Hypotension—Paclitaxel—kidney cancer	3.52e-05	0.000219	CcSEcCtD
Diclofenac—Ill-defined disorder—Capecitabine—kidney cancer	3.51e-05	0.000219	CcSEcCtD
Diclofenac—Headache—Sunitinib—kidney cancer	3.51e-05	0.000218	CcSEcCtD
Diclofenac—Influenza—Doxorubicin—kidney cancer	3.5e-05	0.000218	CcSEcCtD
Diclofenac—Asthma—Doxorubicin—kidney cancer	3.5e-05	0.000218	CcSEcCtD
Diclofenac—Anaemia—Capecitabine—kidney cancer	3.5e-05	0.000218	CcSEcCtD
Diclofenac—Hypersensitivity—Vincristine—kidney cancer	3.49e-05	0.000217	CcSEcCtD
Diclofenac—Eosinophilia—Doxorubicin—kidney cancer	3.47e-05	0.000216	CcSEcCtD
Diclofenac—Nausea—Sorafenib—kidney cancer	3.46e-05	0.000215	CcSEcCtD
Diclofenac—Pancreatitis—Doxorubicin—kidney cancer	3.43e-05	0.000214	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Paclitaxel—kidney cancer	3.43e-05	0.000213	CcSEcCtD
Diclofenac—Malaise—Capecitabine—kidney cancer	3.41e-05	0.000212	CcSEcCtD
Diclofenac—Angina pectoris—Doxorubicin—kidney cancer	3.41e-05	0.000212	CcSEcCtD
Diclofenac—Insomnia—Paclitaxel—kidney cancer	3.4e-05	0.000212	CcSEcCtD
Diclofenac—Vertigo—Capecitabine—kidney cancer	3.4e-05	0.000212	CcSEcCtD
Diclofenac—Asthenia—Vincristine—kidney cancer	3.4e-05	0.000212	CcSEcCtD
Diclofenac—Syncope—Capecitabine—kidney cancer	3.39e-05	0.000211	CcSEcCtD
Diclofenac—Leukopenia—Capecitabine—kidney cancer	3.39e-05	0.000211	CcSEcCtD
Diclofenac—Paraesthesia—Paclitaxel—kidney cancer	3.38e-05	0.00021	CcSEcCtD
Diclofenac—Vomiting—Dactinomycin—kidney cancer	3.37e-05	0.00021	CcSEcCtD
Diclofenac—Bronchitis—Doxorubicin—kidney cancer	3.37e-05	0.00021	CcSEcCtD
Diclofenac—Dyspnoea—Paclitaxel—kidney cancer	3.36e-05	0.000209	CcSEcCtD
Diclofenac—Somnolence—Paclitaxel—kidney cancer	3.35e-05	0.000208	CcSEcCtD
Diclofenac—Palpitations—Capecitabine—kidney cancer	3.34e-05	0.000208	CcSEcCtD
Diclofenac—Rash—Dactinomycin—kidney cancer	3.34e-05	0.000208	CcSEcCtD
Diclofenac—Nausea—Sunitinib—kidney cancer	3.33e-05	0.000207	CcSEcCtD
Diclofenac—Loss of consciousness—Capecitabine—kidney cancer	3.33e-05	0.000207	CcSEcCtD
Diclofenac—Pancytopenia—Doxorubicin—kidney cancer	3.33e-05	0.000207	CcSEcCtD
Diclofenac—Dyspepsia—Paclitaxel—kidney cancer	3.31e-05	0.000206	CcSEcCtD
Diclofenac—Cough—Capecitabine—kidney cancer	3.3e-05	0.000206	CcSEcCtD
Diclofenac—Dysuria—Doxorubicin—kidney cancer	3.27e-05	0.000204	CcSEcCtD
Diclofenac—Decreased appetite—Paclitaxel—kidney cancer	3.27e-05	0.000204	CcSEcCtD
Diclofenac—Hypertension—Capecitabine—kidney cancer	3.27e-05	0.000203	CcSEcCtD
Diclofenac—Upper respiratory tract infection—Doxorubicin—kidney cancer	3.25e-05	0.000203	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.25e-05	0.000202	CcSEcCtD
Diclofenac—Fatigue—Paclitaxel—kidney cancer	3.25e-05	0.000202	CcSEcCtD
Diclofenac—Diarrhoea—Vincristine—kidney cancer	3.24e-05	0.000202	CcSEcCtD
Diclofenac—Pollakiuria—Doxorubicin—kidney cancer	3.23e-05	0.000201	CcSEcCtD
Diclofenac—Asthenia—Gemcitabine—kidney cancer	3.23e-05	0.000201	CcSEcCtD
Diclofenac—Chest pain—Capecitabine—kidney cancer	3.22e-05	0.000201	CcSEcCtD
Diclofenac—Arthralgia—Capecitabine—kidney cancer	3.22e-05	0.000201	CcSEcCtD
Diclofenac—Myalgia—Capecitabine—kidney cancer	3.22e-05	0.000201	CcSEcCtD
Diclofenac—Pain—Paclitaxel—kidney cancer	3.22e-05	0.0002	CcSEcCtD
Diclofenac—Constipation—Paclitaxel—kidney cancer	3.22e-05	0.0002	CcSEcCtD
Diclofenac—Anxiety—Capecitabine—kidney cancer	3.21e-05	0.0002	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	3.2e-05	0.000199	CcSEcCtD
Diclofenac—Photosensitivity reaction—Doxorubicin—kidney cancer	3.2e-05	0.000199	CcSEcCtD
Diclofenac—Weight increased—Doxorubicin—kidney cancer	3.19e-05	0.000198	CcSEcCtD
Diclofenac—Discomfort—Capecitabine—kidney cancer	3.18e-05	0.000198	CcSEcCtD
Diclofenac—Pruritus—Gemcitabine—kidney cancer	3.18e-05	0.000198	CcSEcCtD
Diclofenac—Weight decreased—Doxorubicin—kidney cancer	3.17e-05	0.000197	CcSEcCtD
Diclofenac—Hyperglycaemia—Doxorubicin—kidney cancer	3.16e-05	0.000197	CcSEcCtD
Diclofenac—Dry mouth—Capecitabine—kidney cancer	3.15e-05	0.000196	CcSEcCtD
Diclofenac—Nausea—Dactinomycin—kidney cancer	3.15e-05	0.000196	CcSEcCtD
Diclofenac—Pneumonia—Doxorubicin—kidney cancer	3.14e-05	0.000195	CcSEcCtD
Diclofenac—Dizziness—Vincristine—kidney cancer	3.13e-05	0.000195	CcSEcCtD
Diclofenac—Infestation NOS—Doxorubicin—kidney cancer	3.12e-05	0.000194	CcSEcCtD
Diclofenac—Infestation—Doxorubicin—kidney cancer	3.12e-05	0.000194	CcSEcCtD
Diclofenac—Drowsiness—Doxorubicin—kidney cancer	3.12e-05	0.000194	CcSEcCtD
Diclofenac—Confusional state—Capecitabine—kidney cancer	3.11e-05	0.000194	CcSEcCtD
Diclofenac—Feeling abnormal—Paclitaxel—kidney cancer	3.1e-05	0.000193	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	3.1e-05	0.000193	CcSEcCtD
Diclofenac—Oedema—Capecitabine—kidney cancer	3.09e-05	0.000192	CcSEcCtD
Diclofenac—Gastrointestinal pain—Paclitaxel—kidney cancer	3.08e-05	0.000192	CcSEcCtD
Diclofenac—Diarrhoea—Gemcitabine—kidney cancer	3.08e-05	0.000191	CcSEcCtD
Diclofenac—Renal failure—Doxorubicin—kidney cancer	3.07e-05	0.000191	CcSEcCtD
Diclofenac—Infection—Capecitabine—kidney cancer	3.07e-05	0.000191	CcSEcCtD
Diclofenac—Neuropathy peripheral—Doxorubicin—kidney cancer	3.06e-05	0.00019	CcSEcCtD
Diclofenac—Stomatitis—Doxorubicin—kidney cancer	3.04e-05	0.000189	CcSEcCtD
Diclofenac—Jaundice—Doxorubicin—kidney cancer	3.04e-05	0.000189	CcSEcCtD
Diclofenac—Shock—Capecitabine—kidney cancer	3.04e-05	0.000189	CcSEcCtD
Diclofenac—Conjunctivitis—Doxorubicin—kidney cancer	3.03e-05	0.000189	CcSEcCtD
Diclofenac—Urinary tract infection—Doxorubicin—kidney cancer	3.03e-05	0.000189	CcSEcCtD
Diclofenac—Nervous system disorder—Capecitabine—kidney cancer	3.03e-05	0.000189	CcSEcCtD
Diclofenac—Thrombocytopenia—Capecitabine—kidney cancer	3.02e-05	0.000188	CcSEcCtD
Diclofenac—Tachycardia—Capecitabine—kidney cancer	3.01e-05	0.000188	CcSEcCtD
Diclofenac—Vomiting—Vincristine—kidney cancer	3.01e-05	0.000188	CcSEcCtD
Diclofenac—Skin disorder—Capecitabine—kidney cancer	3e-05	0.000187	CcSEcCtD
Diclofenac—Sweating—Doxorubicin—kidney cancer	2.99e-05	0.000186	CcSEcCtD
Diclofenac—Urticaria—Paclitaxel—kidney cancer	2.99e-05	0.000186	CcSEcCtD
Diclofenac—Rash—Vincristine—kidney cancer	2.99e-05	0.000186	CcSEcCtD
Diclofenac—Hyperhidrosis—Capecitabine—kidney cancer	2.99e-05	0.000186	CcSEcCtD
Diclofenac—Dermatitis—Vincristine—kidney cancer	2.99e-05	0.000186	CcSEcCtD
Diclofenac—Haematuria—Doxorubicin—kidney cancer	2.98e-05	0.000185	CcSEcCtD
Diclofenac—Abdominal pain—Paclitaxel—kidney cancer	2.98e-05	0.000185	CcSEcCtD
Diclofenac—Body temperature increased—Paclitaxel—kidney cancer	2.98e-05	0.000185	CcSEcCtD
Diclofenac—Headache—Vincristine—kidney cancer	2.97e-05	0.000185	CcSEcCtD
Diclofenac—Hepatobiliary disease—Doxorubicin—kidney cancer	2.95e-05	0.000184	CcSEcCtD
Diclofenac—Epistaxis—Doxorubicin—kidney cancer	2.94e-05	0.000183	CcSEcCtD
Diclofenac—Anorexia—Capecitabine—kidney cancer	2.94e-05	0.000183	CcSEcCtD
Diclofenac—Sinusitis—Doxorubicin—kidney cancer	2.93e-05	0.000182	CcSEcCtD
Diclofenac—Agranulocytosis—Doxorubicin—kidney cancer	2.91e-05	0.000181	CcSEcCtD
Diclofenac—Hypotension—Capecitabine—kidney cancer	2.89e-05	0.00018	CcSEcCtD
Diclofenac—Vomiting—Gemcitabine—kidney cancer	2.86e-05	0.000178	CcSEcCtD
Diclofenac—Bradycardia—Doxorubicin—kidney cancer	2.85e-05	0.000178	CcSEcCtD
Diclofenac—Rash—Gemcitabine—kidney cancer	2.83e-05	0.000176	CcSEcCtD
Diclofenac—Dermatitis—Gemcitabine—kidney cancer	2.83e-05	0.000176	CcSEcCtD
Diclofenac—Haemoglobin—Doxorubicin—kidney cancer	2.82e-05	0.000175	CcSEcCtD
Diclofenac—Headache—Gemcitabine—kidney cancer	2.82e-05	0.000175	CcSEcCtD
Diclofenac—Nausea—Vincristine—kidney cancer	2.82e-05	0.000175	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Capecitabine—kidney cancer	2.81e-05	0.000175	CcSEcCtD
Diclofenac—Rhinitis—Doxorubicin—kidney cancer	2.81e-05	0.000175	CcSEcCtD
Diclofenac—Hepatitis—Doxorubicin—kidney cancer	2.8e-05	0.000174	CcSEcCtD
Diclofenac—Haemorrhage—Doxorubicin—kidney cancer	2.8e-05	0.000174	CcSEcCtD
Diclofenac—Insomnia—Capecitabine—kidney cancer	2.79e-05	0.000174	CcSEcCtD
Diclofenac—Hypoaesthesia—Doxorubicin—kidney cancer	2.79e-05	0.000174	CcSEcCtD
Diclofenac—Pharyngitis—Doxorubicin—kidney cancer	2.78e-05	0.000173	CcSEcCtD
Diclofenac—Paraesthesia—Capecitabine—kidney cancer	2.77e-05	0.000173	CcSEcCtD
Diclofenac—Hypersensitivity—Paclitaxel—kidney cancer	2.77e-05	0.000173	CcSEcCtD
Diclofenac—Urinary tract disorder—Doxorubicin—kidney cancer	2.77e-05	0.000172	CcSEcCtD
Diclofenac—Oedema peripheral—Doxorubicin—kidney cancer	2.76e-05	0.000172	CcSEcCtD
Diclofenac—Dyspnoea—Capecitabine—kidney cancer	2.75e-05	0.000171	CcSEcCtD
Diclofenac—Urethral disorder—Doxorubicin—kidney cancer	2.75e-05	0.000171	CcSEcCtD
Diclofenac—Dyspepsia—Capecitabine—kidney cancer	2.72e-05	0.000169	CcSEcCtD
Diclofenac—Visual impairment—Doxorubicin—kidney cancer	2.7e-05	0.000168	CcSEcCtD
Diclofenac—Asthenia—Paclitaxel—kidney cancer	2.7e-05	0.000168	CcSEcCtD
Diclofenac—Decreased appetite—Capecitabine—kidney cancer	2.69e-05	0.000167	CcSEcCtD
Diclofenac—Nausea—Gemcitabine—kidney cancer	2.67e-05	0.000166	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Capecitabine—kidney cancer	2.67e-05	0.000166	CcSEcCtD
Diclofenac—Fatigue—Capecitabine—kidney cancer	2.66e-05	0.000166	CcSEcCtD
Diclofenac—Pruritus—Paclitaxel—kidney cancer	2.66e-05	0.000166	CcSEcCtD
Diclofenac—Erythema multiforme—Doxorubicin—kidney cancer	2.65e-05	0.000165	CcSEcCtD
Diclofenac—Constipation—Capecitabine—kidney cancer	2.64e-05	0.000164	CcSEcCtD
Diclofenac—Pain—Capecitabine—kidney cancer	2.64e-05	0.000164	CcSEcCtD
Diclofenac—Eye disorder—Doxorubicin—kidney cancer	2.62e-05	0.000163	CcSEcCtD
Diclofenac—Tinnitus—Doxorubicin—kidney cancer	2.61e-05	0.000163	CcSEcCtD
Diclofenac—Cardiac disorder—Doxorubicin—kidney cancer	2.6e-05	0.000162	CcSEcCtD
Diclofenac—Flushing—Doxorubicin—kidney cancer	2.6e-05	0.000162	CcSEcCtD
Diclofenac—Diarrhoea—Paclitaxel—kidney cancer	2.58e-05	0.00016	CcSEcCtD
Diclofenac—Feeling abnormal—Capecitabine—kidney cancer	2.55e-05	0.000158	CcSEcCtD
Diclofenac—Angiopathy—Doxorubicin—kidney cancer	2.54e-05	0.000158	CcSEcCtD
Diclofenac—Immune system disorder—Doxorubicin—kidney cancer	2.53e-05	0.000158	CcSEcCtD
Diclofenac—Gastrointestinal pain—Capecitabine—kidney cancer	2.53e-05	0.000157	CcSEcCtD
Diclofenac—Mediastinal disorder—Doxorubicin—kidney cancer	2.53e-05	0.000157	CcSEcCtD
Diclofenac—Chills—Doxorubicin—kidney cancer	2.51e-05	0.000157	CcSEcCtD
Diclofenac—Arrhythmia—Doxorubicin—kidney cancer	2.5e-05	0.000156	CcSEcCtD
Diclofenac—Dizziness—Paclitaxel—kidney cancer	2.49e-05	0.000155	CcSEcCtD
Diclofenac—Alopecia—Doxorubicin—kidney cancer	2.48e-05	0.000154	CcSEcCtD
Diclofenac—Mental disorder—Doxorubicin—kidney cancer	2.46e-05	0.000153	CcSEcCtD
Diclofenac—Urticaria—Capecitabine—kidney cancer	2.45e-05	0.000153	CcSEcCtD
Diclofenac—Abdominal pain—Capecitabine—kidney cancer	2.44e-05	0.000152	CcSEcCtD
Diclofenac—Body temperature increased—Capecitabine—kidney cancer	2.44e-05	0.000152	CcSEcCtD
Diclofenac—Malnutrition—Doxorubicin—kidney cancer	2.44e-05	0.000152	CcSEcCtD
Diclofenac—Erythema—Doxorubicin—kidney cancer	2.44e-05	0.000152	CcSEcCtD
Diclofenac—Flatulence—Doxorubicin—kidney cancer	2.4e-05	0.00015	CcSEcCtD
Diclofenac—Tension—Doxorubicin—kidney cancer	2.39e-05	0.000149	CcSEcCtD
Diclofenac—Vomiting—Paclitaxel—kidney cancer	2.39e-05	0.000149	CcSEcCtD
Diclofenac—Dysgeusia—Doxorubicin—kidney cancer	2.39e-05	0.000149	CcSEcCtD
Diclofenac—Rash—Paclitaxel—kidney cancer	2.37e-05	0.000148	CcSEcCtD
Diclofenac—Dermatitis—Paclitaxel—kidney cancer	2.37e-05	0.000148	CcSEcCtD
Diclofenac—Nervousness—Doxorubicin—kidney cancer	2.37e-05	0.000147	CcSEcCtD
Diclofenac—Back pain—Doxorubicin—kidney cancer	2.36e-05	0.000147	CcSEcCtD
Diclofenac—Headache—Paclitaxel—kidney cancer	2.36e-05	0.000147	CcSEcCtD
Diclofenac—Muscle spasms—Doxorubicin—kidney cancer	2.35e-05	0.000146	CcSEcCtD
Diclofenac—Vision blurred—Doxorubicin—kidney cancer	2.3e-05	0.000143	CcSEcCtD
Diclofenac—Hypersensitivity—Capecitabine—kidney cancer	2.28e-05	0.000142	CcSEcCtD
Diclofenac—Ill-defined disorder—Doxorubicin—kidney cancer	2.26e-05	0.000141	CcSEcCtD
Diclofenac—Anaemia—Doxorubicin—kidney cancer	2.26e-05	0.00014	CcSEcCtD
Diclofenac—Agitation—Doxorubicin—kidney cancer	2.24e-05	0.00014	CcSEcCtD
Diclofenac—Nausea—Paclitaxel—kidney cancer	2.24e-05	0.000139	CcSEcCtD
Diclofenac—Asthenia—Capecitabine—kidney cancer	2.22e-05	0.000138	CcSEcCtD
Diclofenac—Malaise—Doxorubicin—kidney cancer	2.2e-05	0.000137	CcSEcCtD
Diclofenac—Vertigo—Doxorubicin—kidney cancer	2.19e-05	0.000136	CcSEcCtD
Diclofenac—Syncope—Doxorubicin—kidney cancer	2.19e-05	0.000136	CcSEcCtD
Diclofenac—Pruritus—Capecitabine—kidney cancer	2.19e-05	0.000136	CcSEcCtD
Diclofenac—Leukopenia—Doxorubicin—kidney cancer	2.18e-05	0.000136	CcSEcCtD
Diclofenac—Palpitations—Doxorubicin—kidney cancer	2.16e-05	0.000134	CcSEcCtD
Diclofenac—Loss of consciousness—Doxorubicin—kidney cancer	2.14e-05	0.000133	CcSEcCtD
Diclofenac—Cough—Doxorubicin—kidney cancer	2.13e-05	0.000133	CcSEcCtD
Diclofenac—Convulsion—Doxorubicin—kidney cancer	2.11e-05	0.000132	CcSEcCtD
Diclofenac—Diarrhoea—Capecitabine—kidney cancer	2.11e-05	0.000132	CcSEcCtD
Diclofenac—Hypertension—Doxorubicin—kidney cancer	2.11e-05	0.000131	CcSEcCtD
Diclofenac—Arthralgia—Doxorubicin—kidney cancer	2.08e-05	0.000129	CcSEcCtD
Diclofenac—Chest pain—Doxorubicin—kidney cancer	2.08e-05	0.000129	CcSEcCtD
Diclofenac—Myalgia—Doxorubicin—kidney cancer	2.08e-05	0.000129	CcSEcCtD
Diclofenac—Anxiety—Doxorubicin—kidney cancer	2.07e-05	0.000129	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.06e-05	0.000128	CcSEcCtD
Diclofenac—Discomfort—Doxorubicin—kidney cancer	2.05e-05	0.000128	CcSEcCtD
Diclofenac—Dizziness—Capecitabine—kidney cancer	2.04e-05	0.000127	CcSEcCtD
Diclofenac—Dry mouth—Doxorubicin—kidney cancer	2.03e-05	0.000126	CcSEcCtD
Diclofenac—Confusional state—Doxorubicin—kidney cancer	2.01e-05	0.000125	CcSEcCtD
Diclofenac—Anaphylactic shock—Doxorubicin—kidney cancer	1.99e-05	0.000124	CcSEcCtD
Diclofenac—Oedema—Doxorubicin—kidney cancer	1.99e-05	0.000124	CcSEcCtD
Diclofenac—Infection—Doxorubicin—kidney cancer	1.98e-05	0.000123	CcSEcCtD
Diclofenac—Vomiting—Capecitabine—kidney cancer	1.96e-05	0.000122	CcSEcCtD
Diclofenac—Shock—Doxorubicin—kidney cancer	1.96e-05	0.000122	CcSEcCtD
Diclofenac—Nervous system disorder—Doxorubicin—kidney cancer	1.95e-05	0.000122	CcSEcCtD
Diclofenac—Thrombocytopenia—Doxorubicin—kidney cancer	1.95e-05	0.000121	CcSEcCtD
Diclofenac—Rash—Capecitabine—kidney cancer	1.95e-05	0.000121	CcSEcCtD
Diclofenac—Dermatitis—Capecitabine—kidney cancer	1.95e-05	0.000121	CcSEcCtD
Diclofenac—Tachycardia—Doxorubicin—kidney cancer	1.94e-05	0.000121	CcSEcCtD
Diclofenac—Headache—Capecitabine—kidney cancer	1.94e-05	0.00012	CcSEcCtD
Diclofenac—Skin disorder—Doxorubicin—kidney cancer	1.93e-05	0.00012	CcSEcCtD
Diclofenac—Hyperhidrosis—Doxorubicin—kidney cancer	1.92e-05	0.00012	CcSEcCtD
Diclofenac—Anorexia—Doxorubicin—kidney cancer	1.9e-05	0.000118	CcSEcCtD
Diclofenac—Hypotension—Doxorubicin—kidney cancer	1.86e-05	0.000116	CcSEcCtD
Diclofenac—Nausea—Capecitabine—kidney cancer	1.83e-05	0.000114	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.81e-05	0.000113	CcSEcCtD
Diclofenac—Insomnia—Doxorubicin—kidney cancer	1.8e-05	0.000112	CcSEcCtD
Diclofenac—Paraesthesia—Doxorubicin—kidney cancer	1.79e-05	0.000111	CcSEcCtD
Diclofenac—Dyspnoea—Doxorubicin—kidney cancer	1.78e-05	0.00011	CcSEcCtD
Diclofenac—Somnolence—Doxorubicin—kidney cancer	1.77e-05	0.00011	CcSEcCtD
Diclofenac—Dyspepsia—Doxorubicin—kidney cancer	1.75e-05	0.000109	CcSEcCtD
Diclofenac—Decreased appetite—Doxorubicin—kidney cancer	1.73e-05	0.000108	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.72e-05	0.000107	CcSEcCtD
Diclofenac—Fatigue—Doxorubicin—kidney cancer	1.72e-05	0.000107	CcSEcCtD
Diclofenac—Constipation—Doxorubicin—kidney cancer	1.7e-05	0.000106	CcSEcCtD
Diclofenac—Pain—Doxorubicin—kidney cancer	1.7e-05	0.000106	CcSEcCtD
Diclofenac—Feeling abnormal—Doxorubicin—kidney cancer	1.64e-05	0.000102	CcSEcCtD
Diclofenac—Gastrointestinal pain—Doxorubicin—kidney cancer	1.63e-05	0.000101	CcSEcCtD
Diclofenac—Urticaria—Doxorubicin—kidney cancer	1.58e-05	9.85e-05	CcSEcCtD
Diclofenac—Abdominal pain—Doxorubicin—kidney cancer	1.57e-05	9.8e-05	CcSEcCtD
Diclofenac—Body temperature increased—Doxorubicin—kidney cancer	1.57e-05	9.8e-05	CcSEcCtD
Diclofenac—Hypersensitivity—Doxorubicin—kidney cancer	1.47e-05	9.13e-05	CcSEcCtD
Diclofenac—Asthenia—Doxorubicin—kidney cancer	1.43e-05	8.89e-05	CcSEcCtD
Diclofenac—Pruritus—Doxorubicin—kidney cancer	1.41e-05	8.77e-05	CcSEcCtD
Diclofenac—Diarrhoea—Doxorubicin—kidney cancer	1.36e-05	8.48e-05	CcSEcCtD
Diclofenac—Dizziness—Doxorubicin—kidney cancer	1.32e-05	8.2e-05	CcSEcCtD
Diclofenac—Vomiting—Doxorubicin—kidney cancer	1.27e-05	7.88e-05	CcSEcCtD
Diclofenac—Rash—Doxorubicin—kidney cancer	1.26e-05	7.81e-05	CcSEcCtD
Diclofenac—Dermatitis—Doxorubicin—kidney cancer	1.25e-05	7.81e-05	CcSEcCtD
Diclofenac—Headache—Doxorubicin—kidney cancer	1.25e-05	7.76e-05	CcSEcCtD
Diclofenac—Nausea—Doxorubicin—kidney cancer	1.18e-05	7.36e-05	CcSEcCtD
Diclofenac—ALB—Metabolism—PSMD7—kidney cancer	3.55e-06	4.21e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.55e-06	4.21e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—RAF1—kidney cancer	3.54e-06	4.2e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MYC—kidney cancer	3.54e-06	4.2e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.53e-06	4.19e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—SLC2A1—kidney cancer	3.52e-06	4.18e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.51e-06	4.16e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ACHE—kidney cancer	3.47e-06	4.12e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTT1—kidney cancer	3.47e-06	4.12e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ITPR2—kidney cancer	3.47e-06	4.11e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MAPK1—kidney cancer	3.46e-06	4.11e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.42e-06	4.05e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—PIK3CA—kidney cancer	3.41e-06	4.05e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.4e-06	4.04e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PGK1—kidney cancer	3.4e-06	4.04e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ACHE—kidney cancer	3.39e-06	4.02e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTT1—kidney cancer	3.39e-06	4.02e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—BCHE—kidney cancer	3.39e-06	4.02e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—RAF1—kidney cancer	3.38e-06	4.01e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—RELA—kidney cancer	3.37e-06	4e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—BCHE—kidney cancer	3.37e-06	3.99e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.36e-06	3.98e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PTGS2—kidney cancer	3.35e-06	3.98e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—ERBB2—kidney cancer	3.35e-06	3.97e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—SLC5A5—kidney cancer	3.34e-06	3.97e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—LDHB—kidney cancer	3.34e-06	3.96e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—SLC5A5—kidney cancer	3.33e-06	3.94e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—POMC—kidney cancer	3.32e-06	3.94e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GSTP1—kidney cancer	3.31e-06	3.93e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MTOR—kidney cancer	3.3e-06	3.92e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—SCARB1—kidney cancer	3.28e-06	3.9e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—KRAS—kidney cancer	3.27e-06	3.88e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PTGS2—kidney cancer	3.26e-06	3.87e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS1—kidney cancer	3.25e-06	3.86e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—SLC2A1—kidney cancer	3.23e-06	3.83e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—SLC2A1—kidney cancer	3.21e-06	3.81e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—SCARB1—kidney cancer	3.21e-06	3.8e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—POMC—kidney cancer	3.2e-06	3.8e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.2e-06	3.79e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CRABP1—kidney cancer	3.19e-06	3.78e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PSMD7—kidney cancer	3.19e-06	3.78e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GSTP1—kidney cancer	3.18e-06	3.77e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS1—kidney cancer	3.17e-06	3.76e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—IL2—kidney cancer	3.17e-06	3.76e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTT1—kidney cancer	3.16e-06	3.75e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ACHE—kidney cancer	3.16e-06	3.75e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—RAF1—kidney cancer	3.16e-06	3.74e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ABCB1—kidney cancer	3.13e-06	3.72e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.13e-06	3.72e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—ERBB2—kidney cancer	3.12e-06	3.7e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GSTP1—kidney cancer	3.12e-06	3.7e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.12e-06	3.7e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PSMD7—kidney cancer	3.11e-06	3.69e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CDKN1B—kidney cancer	3.1e-06	3.68e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MTOR—kidney cancer	3.08e-06	3.65e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CD4—kidney cancer	3.07e-06	3.65e-05	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PIK3CA—kidney cancer	3.07e-06	3.64e-05	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	3.06e-06	3.63e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HIF1A—kidney cancer	3.06e-06	3.63e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TSC2—kidney cancer	3.05e-06	3.62e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTGS2—kidney cancer	3.05e-06	3.62e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GSTM1—kidney cancer	3.04e-06	3.61e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL2—kidney cancer	3.04e-06	3.6e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—BCHE—kidney cancer	3.02e-06	3.59e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ABCB1—kidney cancer	3.01e-06	3.57e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PIK3CA—kidney cancer	3e-06	3.56e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SCARB1—kidney cancer	2.99e-06	3.55e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.99e-06	3.54e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.99e-06	3.54e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.98e-06	3.54e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ITPR2—kidney cancer	2.96e-06	3.52e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS1—kidney cancer	2.96e-06	3.52e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CCND1—kidney cancer	2.96e-06	3.51e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—JUN—kidney cancer	2.95e-06	3.5e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ABCB1—kidney cancer	2.95e-06	3.5e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—BCHE—kidney cancer	2.95e-06	3.5e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GSTP1—kidney cancer	2.94e-06	3.49e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CTNNB1—kidney cancer	2.93e-06	3.48e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GSTM1—kidney cancer	2.92e-06	3.47e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PTEN—kidney cancer	2.92e-06	3.47e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—SLC5A5—kidney cancer	2.91e-06	3.46e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PSMD7—kidney cancer	2.91e-06	3.45e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—kidney cancer	2.91e-06	3.45e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CA9—kidney cancer	2.89e-06	3.43e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CDKN1B—kidney cancer	2.89e-06	3.43e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CYP1A1—kidney cancer	2.88e-06	3.42e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.88e-06	3.42e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GSTM1—kidney cancer	2.86e-06	3.4e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PTEN—kidney cancer	2.86e-06	3.39e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PTEN—kidney cancer	2.84e-06	3.37e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—SLC2A1—kidney cancer	2.81e-06	3.34e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.8e-06	3.32e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ABCB1—kidney cancer	2.78e-06	3.3e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CYP1A1—kidney cancer	2.77e-06	3.29e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—BCHE—kidney cancer	2.76e-06	3.27e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.73e-06	3.24e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.73e-06	3.24e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CTNNB1—kidney cancer	2.73e-06	3.24e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.72e-06	3.23e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.72e-06	3.22e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CYP1A1—kidney cancer	2.72e-06	3.22e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—POMC—kidney cancer	2.71e-06	3.21e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ACHE—kidney cancer	2.7e-06	3.21e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTT1—kidney cancer	2.7e-06	3.21e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GSTM1—kidney cancer	2.7e-06	3.2e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KIT—kidney cancer	2.7e-06	3.2e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—APC—kidney cancer	2.7e-06	3.2e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—kidney cancer	2.7e-06	3.2e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTP1—kidney cancer	2.69e-06	3.2e-05	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.68e-06	3.18e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTP1—kidney cancer	2.68e-06	3.18e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTEN—kidney cancer	2.66e-06	3.16e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTGS2—kidney cancer	2.65e-06	3.14e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.63e-06	3.12e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—kidney cancer	2.58e-06	3.06e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SCARB1—kidney cancer	2.56e-06	3.04e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTGS2—kidney cancer	2.56e-06	3.03e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.55e-06	3.03e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—MAPK3—kidney cancer	2.55e-06	3.03e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ABCB1—kidney cancer	2.55e-06	3.03e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—BRAF—kidney cancer	2.54e-06	3.01e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ABCB1—kidney cancer	2.54e-06	3.01e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS1—kidney cancer	2.53e-06	3e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PSMD7—kidney cancer	2.48e-06	2.95e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTM1—kidney cancer	2.48e-06	2.94e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTM1—kidney cancer	2.46e-06	2.92e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CRABP1—kidney cancer	2.46e-06	2.92e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAPK3—kidney cancer	2.44e-06	2.89e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.44e-06	2.89e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—MAPK1—kidney cancer	2.43e-06	2.88e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTP1—kidney cancer	2.4e-06	2.85e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MYC—kidney cancer	2.37e-06	2.81e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.37e-06	2.81e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—BCHE—kidney cancer	2.36e-06	2.79e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTP1—kidney cancer	2.35e-06	2.78e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CYP1A1—kidney cancer	2.35e-06	2.78e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP1A1—kidney cancer	2.33e-06	2.77e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SLC5A5—kidney cancer	2.33e-06	2.76e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAPK1—kidney cancer	2.32e-06	2.75e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTEN—kidney cancer	2.31e-06	2.74e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—KRAS—kidney cancer	2.29e-06	2.72e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ITPR2—kidney cancer	2.29e-06	2.71e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ABCB1—kidney cancer	2.28e-06	2.7e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MAPK3—kidney cancer	2.27e-06	2.7e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SLC2A1—kidney cancer	2.25e-06	2.66e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTEN—kidney cancer	2.23e-06	2.64e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.22e-06	2.64e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MYC—kidney cancer	2.21e-06	2.62e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTM1—kidney cancer	2.21e-06	2.62e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—kidney cancer	2.19e-06	2.6e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTP1—kidney cancer	2.19e-06	2.6e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.18e-06	2.59e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MAPK1—kidney cancer	2.16e-06	2.57e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—kidney cancer	2.16e-06	2.56e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTM1—kidney cancer	2.16e-06	2.56e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—POMC—kidney cancer	2.15e-06	2.55e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—RAF1—kidney cancer	2.12e-06	2.51e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PIK3CA—kidney cancer	2.11e-06	2.5e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.1e-06	2.49e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.1e-06	2.48e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ERBB2—kidney cancer	2.09e-06	2.48e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ACHE—kidney cancer	2.09e-06	2.47e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTT1—kidney cancer	2.09e-06	2.47e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ABCB1—kidney cancer	2.08e-06	2.46e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MTOR—kidney cancer	2.07e-06	2.45e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—POMC—kidney cancer	2.07e-06	2.45e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CD4—kidney cancer	2.06e-06	2.45e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PIK3CA—kidney cancer	2.06e-06	2.45e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP1A1—kidney cancer	2.04e-06	2.43e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—kidney cancer	2.04e-06	2.42e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—kidney cancer	2.04e-06	2.42e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—POMC—kidney cancer	2.02e-06	2.4e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTM1—kidney cancer	2.02e-06	2.39e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PIK3CA—kidney cancer	2.01e-06	2.39e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PIK3CA—kidney cancer	2.01e-06	2.38e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SCARB1—kidney cancer	1.97e-06	2.34e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS1—kidney cancer	1.96e-06	2.32e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—kidney cancer	1.95e-06	2.31e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1B—kidney cancer	1.94e-06	2.3e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.93e-06	2.29e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.92e-06	2.27e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PSMD7—kidney cancer	1.92e-06	2.27e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.91e-06	2.27e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—POMC—kidney cancer	1.91e-06	2.26e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.9e-06	2.25e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTEN—kidney cancer	1.88e-06	2.24e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CA—kidney cancer	1.88e-06	2.23e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTP1—kidney cancer	1.87e-06	2.22e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CTNNB1—kidney cancer	1.83e-06	2.17e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—BCHE—kidney cancer	1.82e-06	2.16e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.8e-06	2.13e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PTEN—kidney cancer	1.79e-06	2.12e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ABCB1—kidney cancer	1.77e-06	2.1e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—POMC—kidney cancer	1.75e-06	2.08e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—POMC—kidney cancer	1.74e-06	2.06e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.73e-06	2.06e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTM1—kidney cancer	1.72e-06	2.04e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.72e-06	2.04e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—kidney cancer	1.65e-06	1.96e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.63e-06	1.94e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CA—kidney cancer	1.63e-06	1.93e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—kidney cancer	1.61e-06	1.92e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CA—kidney cancer	1.57e-06	1.87e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.57e-06	1.86e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—POMC—kidney cancer	1.56e-06	1.85e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAPK3—kidney cancer	1.53e-06	1.81e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—POMC—kidney cancer	1.52e-06	1.81e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—kidney cancer	1.52e-06	1.81e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PTEN—kidney cancer	1.5e-06	1.77e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—kidney cancer	1.48e-06	1.76e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAPK1—kidney cancer	1.45e-06	1.72e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTP1—kidney cancer	1.45e-06	1.72e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTEN—kidney cancer	1.44e-06	1.71e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—POMC—kidney cancer	1.42e-06	1.69e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTEN—kidney cancer	1.41e-06	1.67e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—kidney cancer	1.4e-06	1.66e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—kidney cancer	1.39e-06	1.65e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—kidney cancer	1.37e-06	1.63e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ABCB1—kidney cancer	1.37e-06	1.62e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.34e-06	1.59e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CA—kidney cancer	1.33e-06	1.58e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTM1—kidney cancer	1.33e-06	1.58e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTEN—kidney cancer	1.33e-06	1.57e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CA—kidney cancer	1.26e-06	1.49e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.26e-06	1.49e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—kidney cancer	1.25e-06	1.48e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTEN—kidney cancer	1.22e-06	1.44e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—POMC—kidney cancer	1.22e-06	1.44e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—kidney cancer	1.22e-06	1.44e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTEN—kidney cancer	1.21e-06	1.44e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—kidney cancer	1.14e-06	1.35e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTEN—kidney cancer	1.09e-06	1.29e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTEN—kidney cancer	1.06e-06	1.26e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CA—kidney cancer	1.06e-06	1.25e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.01e-06	1.2e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CA—kidney cancer	9.94e-07	1.18e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTEN—kidney cancer	9.91e-07	1.18e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—kidney cancer	9.71e-07	1.15e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—POMC—kidney cancer	9.39e-07	1.11e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CA—kidney cancer	9.37e-07	1.11e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CA—kidney cancer	8.59e-07	1.02e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CA—kidney cancer	8.54e-07	1.01e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTEN—kidney cancer	8.47e-07	1e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CA—kidney cancer	7.67e-07	9.09e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—kidney cancer	7.49e-07	8.89e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CA—kidney cancer	7.48e-07	8.87e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CA—kidney cancer	6.99e-07	8.29e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTEN—kidney cancer	6.53e-07	7.75e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CA—kidney cancer	5.97e-07	7.08e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.61e-07	5.47e-06	CbGpPWpGaD
